Bvf Partners L P/il insider trades
Open-market stock purchases and sales by Bvf Partners L P/il, Director at Immunic, Inc, from SEC Form 4 filings since Jan 7, 2016.
Track record: 58% of 204 scored buys are up 5% or more since purchase, averaging +53%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 16, 2026 | IMUX Immunic, Inc | Bought (not open market) | — |
| Jul 14, 2026 | XOMA XOMA Royalty Corp | Sold (not open market) | — |
| Jul 14, 2026 | XOMA XOMA Royalty Corp | Sold (not open market) | — |
| Jul 14, 2026 | XOMA XOMA Royalty Corp | Sold (not open market) | — |
| Jul 14, 2026 | XOMA XOMA Royalty Corp | Sold (not open market) | — |
| Jun 26, 2026 | KYMR Kymera Therapeutics, Inc | Sold | $66.8M |
| Jun 26, 2026 | KYMR Kymera Therapeutics, Inc | Sold | $12.1M |
| Jun 26, 2026 | KYMR Kymera Therapeutics, Inc | Sold | $5.5M |
| Jun 26, 2026 | KYMR Kymera Therapeutics, Inc | Sold | $89.2M |
| Jun 24, 2026 | KYMR Kymera Therapeutics, Inc | Bought (not open market) | — |
| Jun 18, 2026 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 17, 2026 | MLTX MoonLake Immunotherapeutics | Bought (not open market) | — |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | $6.1M |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | $1.7M |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | $3.1M |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | $9.3M |
| May 14, 2026 | XOMA XOMA Royalty Corp | Bought (not open market) | — |
| Mar 31, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $32.4M |
| Mar 31, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $26.3M |
| Mar 31, 2026 | MLTX MoonLake Immunotherapeutics | Sold | $4.2M |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc | Sold (not open market) | — |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc | Sold (not open market) | — |
Companies traded
- IMUX Immunic, Inc: other filings, last Sep 16, 2026
- XOMA XOMA Royalty Corp: 69 buys, 10 sales, last Jul 14, 2026
- KYMR Kymera Therapeutics, Inc: 45 buys, 4 sales, last Jun 26, 2026
- OLMA Olema Pharmaceuticals, Inc: 11 buys, last Jun 18, 2026
- MLTX MoonLake Immunotherapeutics: 6 sales, last Jun 17, 2026
- RPTX Repare Therapeutics Inc: 27 buys, last Jan 28, 2026
- EPIX ESSA Pharma Inc: 3 sales, last Oct 9, 2025
- CBIO Glycomimetics Inc: other filings, last Jun 13, 2025
- ALLK Allakos Inc: other filings, last May 15, 2025
- PVLA Palvella Therapeutics, Inc: other filings, last Dec 13, 2024
- FDMT 4D Molecular Therapeutics, Inc: other filings, last Nov 8, 2024
- ELDN Eledon Pharmaceuticals, Inc: 18 buys, last Oct 29, 2024
Get free alerts when Bvf Partners L P/il files a new trade →